חזרה לתוצאות החיפוש

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Refractory Rheumatoid Arthritis (RA) · Idiopathic Inflammatory Myopathies (IIMs) · Systemic Sclerosis (SSc) · Rheumatoid Arthritis (RA · IIM · Myositis · Scleroderma · Sjogren Syndrome · Sjogrens Disease

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Artiva Investigational Site Tuscaloosa, Tuscaloosa, Alabama, United States

  • Artiva Investigational Site Phoenix, Phoenix, Arizona, United States

  • Artiva Investigational Site Tucson, Tucson, Arizona, United States

  • Artiva Investigational Site Chula Vista, Chula Vista, California, United States

  • Artiva Investigational Site Covina, Covina, California, United States

  • Artiva Investigational Site Los Alamitos, Los Alamitos, California, United States

  • Artiva Investigational Site Los Angeles, Los Angeles, California, United States

  • Artiva Investigational Site Santa Ana, Santa Ana, California, United States

  • Artiva Investigational Site Tustin, Tustin, California, United States

  • Artiva Investigational Site Jupiter, Jupiter, Florida, United States

  • Artiva Investigational Site Miami, Miami, Florida, United States

  • Artiva Investigational Site Plantation, Plantation, Florida, United States

  • Artiva Investigational Site Gainesville, Gainesville, Georgia, United States

  • Artiva Investigational Site Norcross, Norcross, Georgia, United States

  • Artiva Investigational Site Willowbrook, Willowbrook, Illinois, United States

  • Artiva Investigational Site Iowa, Iowa City, Iowa, United States

  • Artiva Investigational Site Iowa Great Falls, Great Falls, Montana, United States

  • Artiva Investigational Site Charlotte, Charlotte, North Carolina, United States

  • Artiva Investigational Site Charlotte, Charlotte, North Carolina, United States

  • Artiva Investigational Site Statesville, Statesville, North Carolina, United States

  • Artiva Investigational Site Charleston, Charleston, South Carolina, United States

  • Artiva Investigational Site Hixson, Hixson, Tennessee, United States

  • Artiva Investigational Site Jackson, Jackson, Tennessee, United States

  • Artiva Investigational Site Arlington, Arlington, Texas, United States

  • Artiva Investigational Site Bellaire, Bellaire, Texas, United States

  • Artiva Investigational Site Irving, Irving, Texas, United States

  • Artiva Investigational Site Katy, Katy, Texas, United States

  • Artiva Investigational Site Mesquite, Mesquite, Texas, United States

  • Artiva Investigational Site Red Oak, Red Oak, Texas, United States

  • Artiva Investigational Site Woodland, Woodland, Texas, United States

  • Artiva Investigational Site Roanoke, Roanoke, Virginia, United States

  • Artiva Investigational Site Brasília, Brasília, Brasília, Brazil

  • Artiva Investigational Site Cuiabá, Cuiabá, Cuiabá, Brazil

  • Artiva Investigational Site Porto Alegre, Porto Alegre, Porto Alegre, Brazil

  • Artiva Investigational Site Rio Grande, Rio Grande, Porto Alegre, Brazil

  • Artiva Investigational Site Sao Paulo, São Paulo, São Paulo, Brazil

  • Artiva Investigational Site São Paulo, São Paulo, São Paulo, Brazil

  • Artiva Investigational Site Plovdiv, Plovdiv, Plovdiv, Bulgaria

  • Artiva Investigational Site Sofia, Sofia, Bulgaria

  • Artiva Investigational Site Marseille, Marseille, France

  • Artiva Investigational Site Montpellier, Montpellier, France

  • Artiva Investigational Site Toulouse, Toulouse, France

  • Artiva Investigational Site Bonn, Bonn, Bonn, Germany

  • Artiva Investigational Site Munchen, München, Germany

  • Artiva Investigational Site Brescia, Brescia, Italy

  • Artiva Investigational Site Bydgoszcz, Bydgoszcz, Bydgoszcz, Poland

  • Artiva Investigational Site Warszawa, Warsaw, Warszawa, Poland

  • Artiva Investigational Site Vila Nova De Gaia, Vila Nova de Gaia, Portugal

  • Artiva Investigational Site Bucuresti, Bucharest, Romania

  • Artiva Investigational Site Bucharest, Bucharest, Romania

  • Artiva Investigational Site Belgrade, Belgrade, Belgrade, Serbia

  • Artiva Investigational Site Sevila, Seville, Spain

מובילי המחקר

  • Michael Saddekni, M.D., PgDip, BCMAS

    Study Director

    Artiva Therapeutics

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)